The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors - Test2 - elhamkhani - TriplyDB

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

http://www.wikidata.org/entity/Q21092455

about

Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population Thyroid transcription factors in development, differentiation and disease Novel associations for hypothyroidism include known autoimmune risk loci Discovery of common variants associated with low TSH levels and thyroid cancer risk Familial multinodular goiter syndrome with papillary thyroid carcinomas: mutational analysis of the associated genes in 5 cases from 1 Chinese family FOXE1 association with differentiated thyroid cancer and its progression.Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis.USF-1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions.Contribution of transcription factor binding site motif variants to condition-specific gene expression patterns in budding yeast GSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2.Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients.The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.Common single nucleotide polymorphisms in genes related to immune function and risk of papillary thyroid cancer.New insights into FoxE1 functions: identification of direct FoxE1 targets in thyroid cells Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2 An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.Thyroid-specific transcription factors and their roles in thyroid cancer.CpG island methylation profiling in human salivary gland adenoid cystic carcinoma.Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1 Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.Molecular Analysis of TTF-1 and TTF-2 Genes in Patients with Early Onset Papillary Thyroid Carcinoma.The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21)The investigation of foxe1 variations in papillary thyroid carcinoma.The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.Common genetic variants in pituitary-thyroid axis genes and the risk of differentiated thyroid cancer.Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.Human CD1a deficiency is common and genetically regulated.Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk Quantitative assessment of common genetic variants on FOXE1 and differentiated thyroid cancer risk

P2860

Q21133795-8E7D8AE7-EFDC-43DB-8064-A58CE8EB62B2 Q28250485-C76C30A2-32E8-4BB2-B080-C89AFBC33EF0 Q28730714-8F719407-A718-41A5-B68E-5F422AB2415E Q28943471-E4397927-8A51-4E64-8D95-33D11385CA37 Q33589733-FFFB1F2D-D05B-43E4-9EE6-FB4CC872CE7B Q33632412-FD45FB7C-A68B-49D2-99ED-82A03D6D6BB4 Q33906375-0E0F49EC-7B2E-4EE3-9EE4-0CA7EC368FD0 Q34094498-E9182C24-5D1B-4566-A6B5-5B463E446360 Q34145732-98F71192-F485-4FE3-A4E8-4144446E91AE Q34182463-B0E330B4-0047-4E4A-9057-30AC7CB76E36 Q34216085-20C443F0-D750-442D-9CF2-BC3B3191D937 Q34244330-D40B4F6F-E1B2-4E37-A795-0F9D340E9C4F Q34438260-CE6AEBA0-E0BC-4A57-803B-B91F47482C4C Q34519007-DD44B815-61BD-4CB6-904B-E42138777F55 Q34585754-50A807A6-6EC7-45E4-AAB7-3A2B64027E76 Q34599599-109264C0-551D-4A7C-B8D3-27E56D2CD9C6 Q34631671-0F1174CF-6363-431B-B8DE-B460AD4F26B9 Q34722708-A6C0F1DA-1F1D-476B-8927-0CAC787C3C6E Q34811010-2ACA1787-4AC5-4363-A2AD-50440923D68D Q35005124-6F882CFD-2AAF-431C-88F2-0927845032B2 Q35038884-9000D3BB-DECE-4D24-95EB-37346FEDB72B Q35069629-648A3F90-A4B8-456C-9888-E21E501343B9 Q35094487-31730FFE-A9B6-4127-9522-B53F08693298 Q35155420-F5EAF4EB-3FD8-4226-9506-805070656DAB Q35163365-4CFB7CFE-7763-4240-9918-085CE31E58BB Q35302132-BD520E9D-2301-4D8A-89EF-686C0C74DA43 Q35616207-97DF6198-0231-4B7F-B4A9-327D5B46C9B1 Q35766367-D43B3B21-9D38-483D-8BA8-4C7F594BEA3C Q35769369-20FD551D-6858-4C0A-8D31-AEAF366D5205 Q35864632-5E9A4EBF-1256-46B1-8982-89CC1F033896 Q36021583-15FBBCC6-AB5A-4B88-BCCE-7E64D4871DA5 Q36106359-139BCC0D-0B71-4A48-A0FF-91058FCB6556 Q36375528-82348C10-6E97-49BC-B7B0-6147140D9012 Q36716116-8E483555-07A5-4E08-A119-2BBA2944DE75 Q36928017-D4398929-B748-4D9A-843B-BB6ECCF83D1C Q36991284-E4AF433E-9D7B-445C-B10B-88FA5224F10F Q37074059-992EC8D7-795A-4E13-92A6-F0A76E505C7A Q37109318-81229721-AF22-4EF2-9A49-9E88892E0BC9 Q37175876-0CCD9976-4ACF-43B6-AC63-B941A577E06D Q37529666-98805FA6-5BD4-403B-8675-C47AB6D90646

P2860

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

http://www.wikidata.org/entity/Q21092455

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@ast

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en-gb

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@nl

type

label

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@ast

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en-gb

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@nl

altLabel

The Variant rs1867277 in FOXE1 ...... SF1/USF2 Transcription Factors

@en

prefLabel

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@ast

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en-gb

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@nl

P1433

Q21092455-DF03DC3A-16E0-4418-BA90-98CF479423EC

P1476

Q21092455-506712EA-845C-4E8A-AEFC-4F144A5BD0CE

P2093

Q21092455-0DC4661D-3601-43C0-AA28-2C74BD96EE74

Q21092455-11ACF98B-5CE0-42E5-877B-5B618FDA2FBC

Q21092455-151B3BC6-E466-4600-B3F7-08298EEBEF86

Q21092455-177F66A8-000A-4CA6-8B71-3C97688565C7

Q21092455-4F0D3E9E-FFC6-43B2-A730-8A90D15AE174

Q21092455-68F0D575-3794-4837-8AB9-9186D3E1467F

Q21092455-70A64E3E-EB8B-4EB1-B6D9-0713031014B8

Q21092455-79766D81-5D34-48A5-9CE0-6BFF0484B57B

Q21092455-88594075-5CFA-437C-9AED-F85134986518

Q21092455-92B886B6-45BD-4C52-830C-F36849A48121

P2860

Q21092455-08E7DADE-15C6-4784-AB32-F69D5108C764

Q21092455-0C0126FA-1984-4331-9FC2-5C775B551F0D

Q21092455-0C99F844-4C9C-4D46-86BD-5A5864FFBFB9

Q21092455-0FDE9A6F-43EC-4260-9DE6-95D7756E5972

Q21092455-10660147-199E-486A-98B5-AD28DBB91908

Q21092455-11750A33-115B-437E-82C5-11D7C12A4765

Q21092455-1E00B858-9FE5-45D9-9583-B1EE642C6EC1

Q21092455-29C73223-CF1C-4F32-AC94-CFD095A2E814

Q21092455-2BB0D0CD-CC98-4B5A-83FC-49310D8406FA

Q21092455-34385CAD-874E-479B-803F-4507197879C4

P304

Q21092455-6895E350-BEA4-46C7-8444-414CE6607D19

P31

Q21092455-A53FBC01-CA81-4C76-AA50-29AAADF29321

P3181

Q21092455-01970D93-CF88-468F-9F02-E5CBF4EB5F88

P356

Q21092455-422B3E67-CFD4-44D3-846D-437F2E423165

P407

Q21092455-BCE8D1A6-A9EC-4429-86CD-038336097C57

P433

Q21092455-CA36B0AD-E016-424F-90C7-F12D5F530A88

P478

Q21092455-6A394B58-1E02-4C6D-9920-02A4E5F016D6

P50

Q21092455-09CA717A-7851-451A-A8A3-37BCD83E06B1

Q21092455-2D09B5FC-0357-4D70-B329-852B1D6B5D23

Q21092455-345C508F-3EB9-465E-8CE9-33DFECEFD3EC

Q21092455-384D407A-188B-49C7-9141-7AA11384B775

Q21092455-3DE63F4F-3CD2-4E92-9F10-CAF88C904276

Q21092455-7BD0BE8E-B95D-4D6E-A53A-7F331966CC40

Q21092455-9F09B8AA-1F51-40B9-B62C-9E2D07A258A0

Q21092455-B4CFB070-C638-4FDE-8E01-03C8823A1DBE

Q21092455-B6933D98-4D79-4589-94B2-27E2003D2D72

Q21092455-BD4A21DE-D213-42A4-AC1C-5A77FB47BBEB

P577

Q21092455-C9124EBF-0594-44C4-B836-EAEC3F62D5CE

P5875

Q21092455-6C3C2297-D215-4840-A1DC-9E3BE14C6929

P698

Q21092455-435BC4DC-6D5E-4672-95DF-C1BB0694F3B1

P932

Q21092455-5470DE0B-1A5A-47F9-AFC9-1EDA7C9CB942

P3181

P356

JOURNAL.PGEN.1000637

P1433

P1476

The variant rs1867277 in FOXE1 ...... SF1/USF2 transcription factors

@en

P2093

Amparo Meoro

http://www.w3.org/2001/XMLSchema#string

Antonino Jara-Albarrán

http://www.w3.org/2001/XMLSchema#string

Cristina del Peso

http://www.w3.org/2001/XMLSchema#string

Gabriel Giménez

http://www.w3.org/2001/XMLSchema#string

Guillermo Pita

http://www.w3.org/2001/XMLSchema#string

Ignacio Ramos

http://www.w3.org/2001/XMLSchema#string

Isabella Merante-Boschin

http://www.w3.org/2001/XMLSchema#string

Javier Maravall

http://www.w3.org/2001/XMLSchema#string

Joaquín Serrano

http://www.w3.org/2001/XMLSchema#string

Luis Arribas

http://www.w3.org/2001/XMLSchema#string

P2860

DREAM is a Ca2+-regulated transcriptional repressor

Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms

DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription

Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.

Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box

The role of microRNA genes in papillary thyroid carcinoma

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure

The International HapMap Project

Mutations of the BRAF gene in human cancer

P304

e1000637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4374974

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PGEN.1000637

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Pilar Santisteban

Anna González-Neira

Cristina Montero-Conde

Giuseppe Opocher

Mercedes Robledo

Cristina Rodríguez-Antona

Sergio Ruiz-Llorente

J Caballero-Villarraso

P577

2009-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26789825

http://www.w3.org/2001/XMLSchema#string

P698

19730683

http://www.w3.org/2001/XMLSchema#string

P932

2727793

http://www.w3.org/2001/XMLSchema#string